EUVIMEDEUVIMED entdecken
Crossref

Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression

Reiji Yoshimura, Naomichi Okamoto, Yuki Konishi, Atsuko Ikenouchi

Clinical Neuropsychopharmacology and Therapeutics · 2020

DOI: 10.5234/cnpt.11.49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Therapeutics, 2020. Verfasst von Reiji Yoshimura und 3 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yoshimura, R., Okamoto, N., Konishi, Y., & Ikenouchi, A. (2020). Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression. Clinical Neuropsychopharmacology and Therapeutics. https://doi.org/10.5234/cnpt.11.49

Vancouver

Yoshimura R, Okamoto N, Konishi Y, Ikenouchi A. Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression. Clinical Neuropsychopharmacology and Therapeutics. 2020. doi:10.5234/cnpt.11.49

BibTeX
@article{Yoshimura2020,
  author = {Yoshimura, Reiji and Okamoto, Naomichi and Konishi, Yuki and Ikenouchi, Atsuko},
  title = {Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression},
  journal = {Clinical Neuropsychopharmacology and Therapeutics},
  year = {2020},
  doi = {10.5234/cnpt.11.49}
}
Kostenlos starten →